Holmes E H, Hakomori S
J Biol Chem. 1983 Mar 25;258(6):3706-13.
Previous studies indicated that accumulation of alpha-fucosyl-GM1 (IV2FucII3NeuAcGgOse4Cer) and alpha-galactosyl-alpha-fucosyl-GM1 (IV3GalIV2FucII3NeuAcGgOse4Cer) occurs in precancerous livers of rats fed the chemical carcinogen N-2-acetylaminofluorene, before development of hepatoma. Both fucogangliosides were completely absent in normal rat liver as well as in livers of rats fed a nonhepatic carcinogen and tumor promoters (Holmes, E.H., and Hakomori, S. (1982) J. Biol. Chem. 257, 7698-7703). The enzymatic basis of the chemical changes described above is reported in this paper. The alpha-L-fucosyltransferase activity toward GM1 (II2NeuAcGgOse4Cer) as well as asialo-GM1 (GgOse4Cer) was almost undetectable in extracts from normal rat liver, but significant activity of this enzyme was detected in extracts of rat livers after 4 weeks of feeding a diet containing N-2-acetylaminofluorene. The same enzyme activity in cultured rat hepatoma cells was 18- to 47-fold higher than in N-2-acetylaminofluorene-fed rat liver. In contrast, alpha-galactosyltransferase activity with a broad substrate specificity was detected in normal as well as in N-2-acetylaminofluorene-fed liver, although the specific activity of this enzyme in Golgi membranes in precancerous liver was significantly higher than that of normal rat liver. Thus, the appearance of alpha-fucosyl-alpha-galactosyl-GMI in precancerous liver is due to an induction of synthesis of alpha-fucosyl-GMI which is the substrate for the normally existing alpha-galactosyltransferase. The activity of alpha-fucosyltransferase was highly specific toward a substrate structure Gal beta 1 leads to 3GalNAc beta 1 leads to R in GMI or asialo-GMI and showed an anomalous inhibition by a large variety of detergents tested. In contrast, the alpha-galactosyltransferase showed a wide substrate specificity, activated by detergents and Mn2+ ion. Membrane alterations in precancerous and malignant transformation of rat liver is associated with an induction of an unusual alpha-fucosyltransferase which is the key step in synthesis of both fucogangliosides.
先前的研究表明,在给大鼠喂食化学致癌物N-2-乙酰氨基芴后,在肝癌发生之前,α-岩藻糖基-GM1(IV2FucII3NeuAcGgOse4Cer)和α-半乳糖基-α-岩藻糖基-GM1(IV3GalIV2FucII3NeuAcGgOse4Cer)会在大鼠的癌前肝脏中积累。这两种岩藻糖神经节苷脂在正常大鼠肝脏以及喂食非肝致癌物和肿瘤启动剂的大鼠肝脏中完全不存在(霍姆斯,E.H.,和羽田茂,S.(1982年)《生物化学杂志》257,7698 - 7703)。本文报道了上述化学变化的酶学基础。在正常大鼠肝脏提取物中,针对GM1(II2NeuAcGgOse4Cer)以及脱唾液酸GM1(GgOse4Cer)的α-L-岩藻糖基转移酶活性几乎检测不到,但在喂食含N-2-乙酰氨基芴饮食4周后的大鼠肝脏提取物中检测到了该酶的显著活性。培养的大鼠肝癌细胞中的相同酶活性比喂食N-2-乙酰氨基芴的大鼠肝脏中的活性高18至47倍。相比之下,在正常以及喂食N-2-乙酰氨基芴的肝脏中都检测到了具有广泛底物特异性的α-半乳糖基转移酶活性,尽管癌前肝脏高尔基体膜中该酶的比活性显著高于正常大鼠肝脏。因此,癌前肝脏中α-岩藻糖基-α-半乳糖基-GMI的出现是由于α-岩藻糖基-GMI合成的诱导,而α-岩藻糖基-GMI是正常存在的α-半乳糖基转移酶的底物。α-岩藻糖基转移酶的活性对GM1或脱唾液酸GM1中底物结构Galβ1→3GalNAcβ1→R具有高度特异性,并受到所测试的多种去污剂的异常抑制。相比之下,α-半乳糖基转移酶表现出广泛的底物特异性,受去污剂和Mn2 +离子激活。大鼠肝脏癌前和恶性转化过程中的膜改变与一种异常的α-岩藻糖基转移酶的诱导有关,这是两种岩藻糖神经节苷脂合成的关键步骤。